Lexicon Pharmaceuticals (LXRX) EBT (2010 - 2026)
Lexicon Pharmaceuticals' (LXRX) quarterly EBT came in at -$5.3 million in Q1 2026, up 81.51% year-on-year from -$2.9 million in Q1 2025, and up 68.5% on a QoQ basis from -$16.8 million in Q4 2025.
Lexicon Pharmaceuticals (LXRX) EBT (2010 - 2026) Analysis & Trends
Lexicon Pharmaceuticals (LXRX) has 17 years of EBT data on file, last reported at -$5.3 million in Q1 2026.
- On a quarterly basis, EBT rose 81.51% year-over-year to -$5.3 million in Q1 2026; TTM through Mar 2026 was -$43.0 million, a 77.74% increase from a year earlier, with the FY2025 full-year figure at -$60.6 million, up 90.2% from the prior year.
- EBT for Q1 2026 stood at -$5.3 million, up from -$16.8 million in the prior quarter.
- Over the last five years, EBT for LXRX reached as high as -$4.2 million in Q2 2025 and fell as low as -$68.3 million in Q3 2024.
- Historically, EBT has averaged -$34.6 million across 5 years, with a median of -$31.2 million in 2022.
- Across the five-year window, EBT tumbled 146.74% in 2023 and surged 92.75% in 2025, its largest moves.
- Year by year, EBT stood at -$31.2 million in 2022, then tumbled by 67.05% to -$52.2 million in 2023, then increased by 26.14% to -$38.5 million in 2024, then soared by 56.36% to -$16.8 million in 2025, then soared by 68.5% to -$5.3 million in 2026.
- Per Business Quant data, the three most recent EBT figures were -$5.3 million in Q1 2026, -$16.8 million in Q4 2025, and -$16.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Lexicon Pharmaceuticals | 922.55 Mn | 751.90 Mn | 20.99 Mn | -5.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5.30 Mn |
| Dec 31, 2025 | -16.81 Mn |
| Sep 30, 2025 | -16.69 Mn |
| Jun 30, 2025 | -4.17 Mn |
| Mar 31, 2025 | -28.65 Mn |
| Dec 31, 2024 | -38.52 Mn |
| Sep 30, 2024 | -68.26 Mn |
| Jun 30, 2024 | -57.57 Mn |
| Mar 31, 2024 | -50.28 Mn |
| Dec 31, 2023 | -52.16 Mn |
| Sep 30, 2023 | -59.96 Mn |
| Jun 30, 2023 | -51.38 Mn |
| Mar 31, 2023 | -32.70 Mn |
| Dec 31, 2022 | -31.22 Mn |
| Sep 30, 2022 | -24.30 Mn |
| Jun 30, 2022 | -26.15 Mn |
| Mar 31, 2022 | -23.52 Mn |
| Dec 31, 2021 | -25.43 Mn |
| Sep 30, 2021 | -23.13 Mn |
| Jun 30, 2021 | -18.14 Mn |